05/15/2026
For most of modern medicine's history, treatments were designed for the average patient.
The problem? The average patient doesn't exist.
Personalized medicine â also called precision medicine â is changing this. By analyzing an individual's genetics, biomarkers, lifestyle, and environment, researchers and clinicians can now identify which treatments are most likely to work for each specific person.
The implications are profound:
ð§Ž Pharmacogenomics â studying how your genes affect your response to drugs â is now influencing prescribing decisions in oncology, psychiatry, and cardiology.
ðĐš Biomarker-driven trials are replacing "trial and error" prescribing with targeted, evidence-based treatment selection.
ð The same medication can have vastly different effects in different people based on metabolic profile, gut microbiome, and genetic variations.
ð Clinical trials are increasingly designed to identify WHICH patients benefit most â not just whether a drug works on average.
This is medicine finally catching up to the biological reality that we are all different.
At OCR, the studies we participate in are part of this larger revolution â building the evidence base that makes personalized medicine possible.